Kulzer, a wholly owned subsidiary of Mitsui Chemicals, has announced the next phase of its business restructuring to strengthen its focus on priority markets in EMEA and the Americas.

As part of this initiative, Kulzer has consolidated the production of its core product—artificial teeth, which continue to see strong demand in the EMEA region—at its facility in Germany. This consolidation brings together operations previously spread across China and Germany.

The company aims to enhance production efficiency, improve product quality, and ensure a stable supply. The German site will serve as the mother plant, supporting sales expansion and enabling the company to provide comprehensive solutions in its key markets.

This restructuring follows the 2024 renewal of Kulzer’s management structure, which reinforced the company’s lean management practices. The introduction of customer trend analysis through digital transformation in its major markets has strengthened Kulzer’s ability to offer timely and effective solutions to customers while improving sales performance.

As a result, Kulzer has achieved greater operational productivity and agility across its global organization. The company has successfully reduced its workforce by 15 per cent within the sales administration division, aligning its cost ratio with that of leading global competitors.

Looking ahead, Kulzer plans to accelerate transformation initiatives and implement growth-oriented strategies to enhance its overall competitiveness. These efforts are aligned with Mitsui Chemicals’ broader goal of improving profitability in its oral care business by increasing sales revenue and reducing operational costs through organizational strengthening.